abstract |
Disclosed is a pharmaceutical composition effective for the prevention and / or treatment of diseases such as arteriosclerotic disease, hyperlipidemia or dyslipidemia, in which inhibition of cholesteryl ester transfer protein (CETP) is beneficial. General formula (I): Wherein R 1 is alkoxycarbonyl, R 2 is alkyl, R 3 is hydrogen, R 4 is alkylene, R 5 is a substituted heterocyclic group, R 6 , R 7 , R 8 and R 9 are Independently, R 10 represents an optionally substituted aromatic ring or the like, such as hydrogen, alkyl, alkoxy and the like. Or a pharmacologically acceptable salt thereof as an active ingredient. [Selection figure] None |